Evidence map›Paper›PMID 39897649›Full record

ArticleMethodsX2025

Adaptation of an

Hana Farizah Zamri, Mohammad Ridhuan Mohd Ali, Ahmad Izzan Irfan Sha'ari, Nurul Husna Mohd Mazalan, Norazah Ahmad, Nur Asyura Nor Amdan, Nusaibah Abdul Rahim, Zakuan Zainy Deris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hana Farizah ZamriDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan 16150, Malaysia.
Mohammad Ridhuan Mohd AliBacteriology Unit, Institute for Medical Research (IMR), Malaysian Ministry of Health, Seksyen U13 Setia Alam, Shah Alam, Selangor 40170, Malaysia.
Ahmad Izzan Irfan Sha'ariBacteriology Unit, Institute for Medical Research (IMR), Malaysian Ministry of Health, Seksyen U13 Setia Alam, Shah Alam, Selangor 40170, Malaysia.
Nurul Husna Mohd MazalanBacteriology Unit, Institute for Medical Research (IMR), Malaysian Ministry of Health, Seksyen U13 Setia Alam, Shah Alam, Selangor 40170, Malaysia.
Norazah AhmadBacteriology Unit, Institute for Medical Research (IMR), Malaysian Ministry of Health, Seksyen U13 Setia Alam, Shah Alam, Selangor 40170, Malaysia.
Nur Asyura Nor AmdanBacteriology Unit, Institute for Medical Research (IMR), Malaysian Ministry of Health, Seksyen U13 Setia Alam, Shah Alam, Selangor 40170, Malaysia.
Nusaibah Abdul RahimDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Zakuan Zainy DerisDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan 16150, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-clinical pharmacokinetic-pharmacodynamic (PKPD) models are crucial in the initial design of drug-dosage regimens and in drug development but has rarely been employed for testing high-risk organisms due to stringent handling procedures.

Indexed as

Biological hazardBurkholderia pseudomalleiCeftazidimeIn vitro one-compartment chemostat for evaluating ceftazidime PK/PD against B. pseudomalleiOne-compartment pharmacokinetic modelTier 1 select agent

Identifiers

PMID39897649
PMCPMC11782592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.